Hepatitis C and Liver Transplants - An Overview

Introduction

In Japan, the United States, and Europe, the most common cause of liver transplantation is liver cirrhosis (liver damage causing scarring and resulting in liver failure) brought on by chronic hepatitis C. All liver transplant recipients have reinfection after the procedure, and within three years, chronic liver disease manifests in at least 70 percent of patients, advancing at a faster rate than non-transplant cases. These data demonstrate the need for a more thorough comprehension of hepatitis C infection and the range of possible treatments.

What Is Hepatitis C Infection?

Hepatitis C is a viral infection that damages the liver and can be fatal. It is both acute (short-term) and chronic (long-term) sickness. The virus is spread by contact with contaminated blood, which can occur when people share syringes or needles or during medical operations like transfusions using unscreened blood supplies.

Hepatitis C can cause fever, lethargy, nausea, vomiting, abdominal discomfort, jaundice (yellowing of the skin or eyes), and fatigue. Although it cannot be prevented, it can be managed using antiviral drugs. Early detection and treatment are essential to avoid major liver damage and to improve long-term health outcomes.

Most acute hepatitis C infections do not cause life-threatening illness and are usually asymptomatic. Thirty to forty-five percent of those infected with the virus naturally recover from it without medical intervention in six months. However, the remaining 70 percent (55 to 85 percent) of people will have a chronic hepatitis C infection. Within 20 years, there is a 15 percent to 30 percent chance of cirrhosis development in patients with persistent infections.

Why Is Hepatitis C Important for Liver Transplant Recipients?

For recipients of liver transplants, the hepatitis C virus (HCV) is very crucial for several reasons:

• Cause of Liver Disease: End-stage liver disease is primarily caused by chronic HCV infection in North America and Europe, regions that perform a large number of liver transplants.

• Recurrence Following Transplant: Nearly all individuals who have previously contracted HCV will experience a relapse of the virus following a liver transplant.

• Risk from Blood Transfusions or Donor: Blood transfusions given around the time of the transplant may potentially spread HCV.

• Financial Impact: Liver transplantation is a costly treatment for persistent HCV infection for the healthcare system.

Histological hepatitis, primarily from HCV, is detected in 14 to 35 percent of liver transplant recipients and is not brought on by HBV (hepatitis B virus) or cytomegalovirus (CMV). After a transplant, almost all patients who had HCV before the procedure will experience a relapse of the virus. The genetic sequencing of the virus has verified this.

In immunosuppressed patients, standard serological assays frequently underestimate the amount of HCV present. Patients with repeated infections have higher HCV-RNA ( (ribonucleic acid) levels, according to more precise testing such as the B-DNA (deoxyribonucleic acid) assay. Post-transplant HCV infection is typically less severe than post-transplant HBV infection. However, the long-term implications are still unknown. Many people continue to have no symptoms. Due to the weakened immune systems, it is thought that certain patients may have elevated amounts of HCV-RNA without exhibiting liver damage.

What Are the Evaluations Done Before Liver Transplantation for Hepatitis C Patients?

Evaluations carried out for patients under consideration for liver transplant surgery include:

• Full Medical History and Physical Examination: Determine any other medical issues and evaluate general health.

• Liver Disease Assessment: Examine the condition of the liver to determine the prognosis in the absence of a transplant.

• Lung and Heart Evaluation: Examine the heart and lungs thoroughly to ensure these organs are in good working order.

• Blood Work: Conduct a range of blood tests to assess liver function and general health.

• Screening for Cancer: Look for any cancer that could interfere with the transplant procedure.

• Evaluation and Management of Illnesses: Examine and handle bacterial, viral, or fungal illnesses.

• Updates on Vaccinations: Verify that the HPV (human papillomavirus), DPT (diphtheria-pertussis-tetanus), influenza (respiratory infection caused by virus), and pneumonia (lung infection) shots have been recently provided.

• Bone Density Testing: Determine osteoporosis (brittle and fragile bone) risk by assessing bone health.

• Anesthesia Evaluation: Determine which anesthesia is appropriate for the procedure.

• Screening for Mental Health and Social Support: Examine mental health and determine available social support.

• Nutritional Evaluation: Review eating patterns and dietary requirements for nutritional evaluation.

Through this thorough evaluation, individuals are guaranteed to be in optimal condition for both surgery and rehabilitation.

How Is Liver Transplant Surgery Performed for Hepatitis C?

When performing liver transplant surgery for hepatitis C patients, medical professionals remove the diseased liver and replace it with a donor's liver. Although it usually takes eight hours, the treatment might take up to twelve hours. The surgeons must connect structures to the new liver throughout the procedure to guarantee adequate blood flow and bile drainage. The hepatic artery, the portal vein (a blood vessel that supplies the liver with blood from the pancreas, spleen, intestines, and gallbladder), the bile duct (carries bile), and the inferior vena cava (the largest vein that carries deoxygenated blood to the heart from the lower body part) are some of these structures.

Following surgery, the patient spends a few hours in a recovery room before being sent to the intensive care unit (ICU). The medical team closely observes the transplant recipient over several days. The majority of transplant patients spend roughly two weeks in the hospital.

What Are the Post-operative Guidelines After a Liver Transplant?

A liver transplant recipient needs to have lifelong outpatient follow-up with their transplant care team, which includes phone calls, video conferences, and in-person sessions. Regular blood tests and examinations are part of this continuing care, which also reviews the side effects and compliance of immunosuppressant medication and helps identify and treat any transplant issues, such as organ rejection. The team also supports the recipient's carers. Taking all prescribed medications, especially immunosuppressants, as directed by the doctor, seeing a doctor before starting any new medications or supplements, bolstering the immune system, talking about the risks of pregnancy and using contraceptives, getting regular cancer screenings, identifying the signs of organ rejection, and staying up to date on vaccinations avoid live vaccines are all crucial care practices for maintaining a healthy new liver. According to the National Health Service in the United Kingdom, full recovery from a liver transplant can take up to a year, even though many patients can resume some activities in a few weeks.

Conclusion

Untreated chronic hepatitis C virus (HCV) infections can lead to serious liver consequences, including liver cancer and cirrhosis. A doctor could suggest a liver transplant in situations where there is severe liver disease. Liver failure caused by HCV might be fatal if therapy is not received. A person may be eligible for a transplant following an assessment. They must concentrate on keeping themselves healthy while waiting for a donated organ. Recovery from the procedure, which replaces the injured liver with a donor organ, can take up to a year. Regular check-ups are required after the transplant to guarantee the patient's continuing excellent health.